Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Auris Medical completes enrollment in AM-111 trial

April 24, 2012

Study reveals new therapeutic use for phosphodiesterase 5 inhibitors

Feb. 24, 2012

Pergamum begins phase II DPK-060 trial in outer ear infections

Jan. 17, 2012

JNK inhibitor prevents hearing loss due to transient cochlear ischemia in preclinical study

Jan. 12, 2012

Phage Pharmaceuticals submits IND for first-in-class therapeutic

Dec. 27, 2011

Second milestone reached in GenVec/Novartis collaboration

Dec. 7, 2011

Peptide P-13 ameliorates experimental otitis media

July 14, 2011

Sanofi and Audion Therapeutics to develop treatments for hearing loss

June 17, 2011

Sound Pharmaceuticals begins trial of SPI-1005 for hearing loss induced by loud music

June 8, 2011

Otonomy reports encouraging phase Ib data on OTO-104 in Meniere's disease

May 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...